Johnson & Johnson (JNJ) Change in Receivables (2009 - 2026)

Johnson & Johnson has disclosed Change in Receivables across 18 years of filings, most recently posting $595.0 million for Q1 2026.

• Change in Receivables for Q1 2026 came in at $595.0 million, down 35.75% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.5 billion (up 37.7% YoY), and the FY2025 annual result was $1.8 billion, up 338.67% from the prior year.
• Change in Receivables came in at $595.0 million for Q1 2026 at Johnson & Johnson, up from -$391.0 million in the prior quarter.
• In the past five years, Change in Receivables ranged from a high of $1.4 billion in Q2 2025 to a low of -$853.0 million in Q4 2024.
• The 5-year median for Change in Receivables is $252.0 million (2023), against an average of $220.3 million.
• Peak annual rise in Change in Receivables reached 416.67% in 2024, while the deepest fall reached 275.77% in 2024.
• Johnson & Johnson's Change in Receivables stood at $427.0 million in 2022, then tumbled by 153.16% to -$227.0 million in 2023, then slumped by 275.77% to -$853.0 million in 2024, then surged by 54.16% to -$391.0 million in 2025, then soared by 252.17% to $595.0 million in 2026.
• The last three Change in Receivables figures came in at $595.0 million (Q1 2026), -$391.0 million (Q4 2025), and -$111.0 million (Q3 2025), per Business Quant data.